Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program by Jean Addington, Lu Liu, Amy Braun, Andrea Auther, Monica E. Calkins, Barbara A. Cornblatt, Cheryl M. Corcoran, Paolo Fusar-Poli, Melissa J. Kerr, Catalina V. Mourgues-Codern, Angela R. Nunez, Dominic Oliver, Gregory P. Strauss, Barbara C. Walsh, Luis K. Alameda, Celso Arango, Nicholas J. K. Breitborde, Matthew R. Broome, Kristin S. Cadenhead, Ricardo E. Carrion, Eric Yu Hai Chen, Jimmy Choi, Michael J. Coleman, Philippe Conus, Covadonga M. Diaz-Caneja, Dominic Dwyer, Lauren M. Ellman, Masoomeh Faghankhani, Pablo A. Gaspar, Carla Gerber, Louise Birkedal Glenthøj, Leslie E. Horton, Christy Hui, Grace R. Jacobs, Joseph Kambeitz, Lana Kambeitz-Ilankovic, Matcheri S. Keshavan, Sung-Wan Kim, Nikolaos Koutsouleris, Jun Soo Kwon, Kerstin Langbein, Kathryn E. Lewandowski, Daniel Mamah, Patricia J. Marcy, Daniel H. Mathalon, Vijay A. Mittal, Merete Nordentoft, Godfrey D. Pearlson, Nora Penzel, Jesus Perez, Diana O. Perkins, Albert R. Powers, Jack Rogers, Fred W. Sabb, Jason Schiffman, Jai L. Shah, Steven M. Silverstein, Stefan Smesny, William S. Stone, Andrew Thompson, Judy L. Thompson, Rachel Upthegrove, Swapna Verma, Jijun Wang, Heather M. Wastler, Alana Wickham, Inge Winter-van Rossum, Daniel H. Wolf, Sylvain Bouix, Ofer Pasternak, Rene S. Kahn, Carrie E. Bearden, John M. Kane, Patrick D. McGorry, Kate Buccilli, Barnaby Nelson, Martha E. Shenton, Scott W. Woods, the Accelerating Medicines Partnership® -Schizophrenia, Alison R. Yung

Get full text